Showing 20,601 - 20,620 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.20s Refine Results
  1. 20601

    Image_2_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff by Biswas Neupane (2167513)

    Published 2020
    “…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”
  2. 20602

    Image_1_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff by Biswas Neupane (2167513)

    Published 2020
    “…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”
  3. 20603

    Mean fire return interval (mFRI) estimate 1976–2000. by Michael L. Mann (2636518)

    Published 2016
    “…<p>Mean fire return interval (mFRI) estimate 1976–2000 (A), and its change from the historical period (1951–1975) (B). …”
  4. 20604
  5. 20605
  6. 20606
  7. 20607

    Measurement of Na<sup>+</sup> ratio in the TE and blastocyst cross-sectional area in Group A. by Ayaka Fujishima (21221913)

    Published 2025
    “…Group A included 11 embryos (Embryo Nos. 1–11) and demonstrated an initial decrease in Na<sup>+</sup> concentration within the ROI (correspomding to theTE), followed by either a plateau or a gradual increase. …”
  8. 20608
  9. 20609

    DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  10. 20610

    DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  11. 20611

    DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  12. 20612

    DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  13. 20613

    DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  14. 20614

    DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
  15. 20615
  16. 20616
  17. 20617

    Model sensitivity analysis to parameters: <i>k</i><sub>5,<i>P</i></sub>, <i>K</i><sub><i>a</i></sub>, <i>K</i><sub><i>PLC</i></sub>, <i>V</i><sub><i>SERCA</i></sub> and <i>β</i>. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    “…<b>(D)</b> Decreased <i>V</i><sub><i>SERCA</i></sub> (BV of 0.9 μM s<sup>-1</sup>) increased frequency and duration of the Ca<sup>2+</sup> signal to the point of observing constant activity, whereas increased <i>V</i><sub><i>SERCA</i></sub> decreased frequency to the point of loss of signal in a 60 minute simulation. …”
  18. 20618
  19. 20619
  20. 20620

    DRP2B is partially required for flg22-induced endocytosis of FLS2. by John M. Smith (676719)

    Published 2014
    “…All experiments were repeated at least three independent times with similar results. Values are mean ± SE. Statistical analysis was done as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004578#ppat-1004578-g001" target="_blank">Fig. 1</a>.…”